CCR4 and CCR10 are expressed on epidermal keratinocytes and are involved in cutaneous immune reaction

Cytokine

Volumn 44, Issue 1, 2008, Pages 172-178

  Fujimoto, Seiki ^a   Uratsuji, Hideya ^a   Saeki, Hidehisa ^a   Kagami, Shinji ^a   Tsunemi, Yuichiro ^a   Komine, Mayumi ^a   Tamaki, Kunihiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

CCL17; CCL27; CCR10; CCR4; Keratinocytes

Indexed keywords

CHEMOKINE RECEPTOR CCR10; CHEMOKINE RECEPTOR CCR4; CUTANEOUS T CELL ATTRACTING CHEMOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12P40; MESSENGER RNA; NERVE GROWTH FACTOR; THYMUS AND ACTIVATION REGULATED CHEMOKINE;

ARTICLE; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNITY; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN;

CELL MOVEMENT; CHEMOKINE CCL17; CHEMOKINE CCL27; EPIDERMIS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-12; KERATINOCYTES; MALE; NERVE GROWTH FACTOR; RECEPTORS, CCR10; RECEPTORS, CCR4; RNA, MESSENGER;

EID: 52949116032     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2008.07.472     Document Type: Article

References (28)

1. Rot A., and von Andrian U.H. Chemokines in innate and adaptive host defense: basic chemokinase grammar for immune cells. Annu Rev Immunol 22 (2004) 891-928
2. Graham G.J., and McKimmie C.S. Chemokine scavenging by D6: a movable feast?. Trends Immunol 27 (2006) 381-386
3. Kakinuma T., Nakamura K., Wakugawa M., Mitsui H., Tada Y., Saeki H., et al. Thymus and activation-regulated chemokine in atopic dermatitis: serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol 107 (2001) 535-541
4. Komine M., Kakinuma T., Kagami S., Hanakawa Y., Hashimoto K., and Tamaki K. Mechanism of thymus- and activation-regulated chemokine (TARC)/CCL17 production and its modulation by roxithromycin. J Invest Dermatol 125 (2005) 491-498
5. Tsunemi Y., Saeki H., Nakamura K., Nagakubo D., Nakayama T., Yoshie O., et al. CCL17 transgenic mice show an enhanced Th2-type response to both allergic and non-allergic stimuli. Eur J Immunol 36 (2006) 2116-2127
6. Kakinuma T., Saeki H., Tsunemi Y., Fujita H., Asano N., Mitsui H., et al. Increased serum cutaneous T cell-attracting chemokine (CCL27) levels in patients with atopic dermatitis and Psoriasis vulgaris. J Allergy Clin Immunol 111 (2003) 592-597
7. Kagami S., Saeki H., Komine M., Kakinuma T., Nakamura K., Tsunemi Y., et al. CCL28 production in HaCaT cells was mediated by different signal pathways from CCL27. Exp Dermatol 15 (2006) 95-100
8. Kagami S., Saeki H., Tsunemi Y., Nakamura K., Kuwano Y., Komine Y., et al. CCL27 transgenic mice showed enhanced contact hypersensitivity reaction to Th2 but not Th1, stimuli. Eur J Immunol 38 (2008) 647-657
9. Reiss Y., Proudfoot A.E., Power C.A., Campbell J.J., and Butcher E.C. CC chemokine receptor (CCR)4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin. J Exp Med 194 (2001) 1541-1547
10. Homey B., Alenius H., Müller A., Soto H., Bowman E.P., Yuan W., et al. CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat Med 8 (2002) 157-165
11. Nanki T., and Lipsky P.E. Lack of correlation between chemokine receptor and T(h)1/T(h)2 cytokine expression by individual memory T cells. Int Immunol 12 (2000) 1659-1667
12. Scala S., Giuliano P., Ascierto P.A., Ierano C., Franco R., Napolitano M., et al. Human melanoma metastases express functional CXCR4. Clin Cancer Res 12 (2006) 2427-2433
13. Vestergaard C., Johanse C., Christenssen U., Jus H., Hohwy T., and Deleura M. TARC augments TNF-α induced CTACK production in keratinocytes. Exp Dermatol 13 (2004) 551-557
14. Murakami T., Cardones A.R., Finkelstein S.E., Restifo N.P., Klaunberg B.A., Nestle F.O., et al. Immune evasion by murine melanoma mediated through CC chemokine receptor-10. J Exp Med 198 (2003) 1337-1347
15. Campbell J.J., Haraldsen G., Pan J., Rottman J., Qin S., Ponath P., et al. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature 400 (1999) 776-780
16. Kakinuma T., Wakugawa M., Nakamura K., Hino H., Matsushima K., and Tamaki K. High level of thymus and activation-regulated chemokine in blister fluid and sera of patients with bullous pemphigoid. Br J Dermatol 148 (2003) 203-210
17. Kakinuma T., Sugaya M., Nakamura K., Kaneko F., Wakugawa M., Matsushima K., et al. Thymus and activation-regulated chemokine (TARC/CCL17) in mycosis fungoides serum TARC levels reflect the disease activity of mycosis fungoides. J Am Acad Dermatol 48 (2003) 23-30
18. Zheng X., Nakamura K., Furukawa H., Nishibu A., Takahashi M., Tojo M., et al. Demonstration of TARC and CCR4 mRNA expression and distribution using in situ RT-PCR in the lesional skin of atopic dermatitis. J Dermatol 30 (2003) 26-32
19. Morita E., Hiragun T., Mihara S., Kaneko S., Matsuo H., Zhang Y., et al. Determination of thymus and activation-regulated chemokine (TARC)-contents in scales of atopic dermatitis. J Dermatol Sci 34 (2004) 237-240
20. Kanda N., Mitsui H., and Watanabe S. Prostaglandin E2 suppresses CCL27 production through EP2 and EP3 receptors in human keratinocytes. J Allergy Clin Immunol 114 (2004) 1403-1409
21. Hamid Q., Naseer T., Minshall E.M., Song Y.L., Boguniewicz M., and Leung D.Y. In vivo expression of IL-12 and IL-13 in atopic dermatitis. J Allergy Clin Immunol 98 (1996) 225-231
22. Yamada N., Wakugawa M., Kuwata S., Nakagawa H., and Tamaki K. Changes in eosinophil and leukocyte infiltration and expression of IL-6 and IL-7 messenger RNA in mite allergen patch test reactions in atopic dermatitis. J Allergy Clin Immunol 98 (1996) S201-S206
23. Ohmen J.D., Hanifin J.M., Nickoloff B.J., Rea T.H., Wyzykowski R., Kim J., et al. Overexpression of IL-10 in atopic dermatitis. Contrasting cytokine patterns with delayed-type hypersensitivity reactions. J Immunol 154 (1995) 1956-1963
24. Pastore S., Fanales-Belasio E., Albanesi C., Chinni L.M., Giannetti A., and Girolomoni G. Granulocyte macrophage colony-stimulating factor is overproduced by keratinocytes in atopic dermatitis. Implications for sustained dendritic cell activation in the skin. J Clin Invest 99 (1997) 3009-3017
25. Dou Y.C., Hagströmer L., Emtestam L., and Johansson O. Increased nerve growth factor and its receptors in atopic dermatitis: an immunohistochemical study. Arch Dermatol Res 298 (2006) 31-37
26. Devalaraja R.M., Nanney L.B., Qian Q., Du J., Yu Y., Devalaraja M.N., et al. Delayed wound healing in CXCR2 knockout mice. J Invest Dermatol 115 (2000) 234-244
27. Rennekampff H.O., Hansbrough J.F., Kiessig V., Dore C., Sticherling M., and Schröder J.M. Bioactive interleukin-8 is expressed in wounds and enhances wound healing. J Surg Res 93 (2000) 41-54
28. Gillitzer R., and Goebeler M. Chemokines in cutaneous wound healing. J Leukoc Biol 69 (2001) 513-521